
IndraLab
Statements
sparser
"These findings not only expand our understanding of the mechanisms underlying the beneficial effects of hUC-MSC and hUC-MSC-EV in mitigating CIRI and the regulation of FUNDC1 metabolism but also highlight the USP35-FUNDC1 axis as a therapeutical target for the treatment of symptoms arising from CIRI."